Fig. 5From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infectionsSummary of concentration data at pH 9.35 (0–180 min). Dissolution of Yomesan-niclosamide at niclosamide equivalents of 300 µM, 600 µM, and 1 mM in nominal 9.33 TB (final pHs ~ 9.2). 180-min time points average to 179.4 µM ± 11.4 µM. Initial rates of dissolution are also shownBack to article page